Navigation Links
Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
Date:4/18/2011

tions, including ACS and acute chest syndrome, as well as chronic diseases, such as stable coronary artery disease (CAD).  In Anthera's FRANCIS Phase 2 clinical study in ACS patients, treatment with varespladib improved independent markers of cardiovascular risk including CRP, IL-6, LDL-C and varespladib's target enzyme, sPLA2.  Recent analysis of data from diabetic patients in the same Phase 2 study demonstrated treatment with varespladib was associated with early and statistically significant reductions in these prognostic inflammatory markers of cardiovascular risk.  In February 2010, Anthera received an SPA from the U.S. FDA for the VISTA-16 Phase 3 study for the use of varespladib in treating high-risk ACS patients.  The next substantial review of clinical safety and efficacy data will be conducted after 50 percent of the anticipated primary endpoints have occurred.  At this review the DSMB will conduct the first prescribed statistical efficacy review of the primary endpoint of the VISTA-16 Study.  This review is expected to take place in the second half of 2011.    

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease (CAD). Anthera's Phase 2 product candidate, A-623, targets elevated levels of B-lymphocyte stimulator (BAFF) which has been associated with a variety of B-Cell mediated autoimmune diseases, including systemic lupus erythema
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
2. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
3. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
4. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
5. Anthera Announces Update Call Regarding Vial Problems
6. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
7. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
8. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
9. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
10. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
11. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Baptist Health Lexington ... to receive full Atrial Fibrillation with Electrophysiology Services ... (SCPC). Atrial fibrillation is the most common cardiac ... in some cases can lead to stroke and possible death. ... States have atrial fibrillation and the numbers are ...
(Date:12/19/2014)... France , Dec. 19, 2014  Eli Lilly ... (Euronext Paris: FR0011184241 – ADOC) today announced a worldwide ... as BioChaperone Lispro, for treatment in people with type ... Adocia,s proprietary BioChaperone® technology and is currently in Phase ... BioChaperone Lispro with the goal of optimizing glucose levels ...
(Date:12/17/2014)... Alemania, December 17, 2014 Los ... con un alto nivel de gasto en investigación y ... 2013/14 (finalizado el 30 de septiembre de 2014) ZEISS ... 4.287 millones de euros (año anterior: 4.190 millones de ... desfavorables. Las ganancias (EBIT) crecieron un 14 por ciento, ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS confirma su posición en un entorno difícil 2
(Date:12/21/2014)... (PRWEB) December 21, 2014 Theme ... announced a new intro plugin for Final Cut Pro ... pictures, videos, logos, and more with absolute ease.” Said ... our users the tools needed to easily animate their ... Final Cut Pro X users to animate pictures, videos, ...
(Date:12/21/2014)... Downey, CA (PRWEB) December 21, 2014 The ... toy drive in the Santa Ana and Whittier offices. The ... help brighten the lives of patients and their families during ... to reach out to approximately 70 children between both offices. ... With the help of Target’s community service team, store managers ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly bamboo flooring ... bamboo flooring promotion for the coming 2015. , ... and offers the best bamboo products and services ... all customers can enjoy a special discount, up ... BambooIndustry.com from press releases. , The bamboo flooring ...
(Date:12/20/2014)... 20, 2014 An improving macroeconomic landscape ... benefited the Massage Services industry over the ... industry products, the anticipated 1.0% annualized increase in per ... consumers with the means to afford additional massages. “While ... massage in a given year has declined from 2009 ...
(Date:12/20/2014)... The print component of Healthy Aging is distributed within ... copies and an estimated readership of 420,000. The digital ... strategy and across a network of top news sites ... the campaign, click here . , The publication ... CTV’s The Social. Lainey Lui, Melissa Grelo, Traci ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2
... market most aggressively to physicians and patients tend to offer ... phenomenon described as the "inverse benefit law" in a paper ... Published online Thursday, Jan. 13 in the American ... of blockbuster drugs due to safety concerns and finds a ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, Jan. ... heartening medical progress continued to arrive Thursday, five days after ... an assassin,s bullet. Giffords, doctors at University Medical Center ... keep her eyes open for up to 15 minutes at ...
... (HealthDay News) -- Differences in income, gender and race ... prematurely, a federal government report released Thursday shows. ... live healthy lives, disparities persist, according to the U.S. ... low-income people have five to 11 times fewer healthy ...
... from training programs that put them behind the wheelin a ... skills. That,s the conclusion of a new article published in ... the Association for Psychological Science. Older people are ... Some states and provinces test older drivers, hoping to get ...
... AMES, Iowa Advancements in understanding rotational motion in ... causes of deadly diseases, such as Alzheimer,s, according to ... of Energy,s Ames Laboratory and faculty member at Iowa ... article entitled "Resolving Rotational Motions of Nano-objects in Engineered ...
... Virginia Tech-Wake Forest University Center for Injury Biomechanics ( ... from the U.S. Army Medical Research and Materiel Command ... brain and eye injuries in military personnel. Specifically, blast ... computational models. Given improvements in helmet design and body ...
Cached Medicine News:Health News:Inverse benefits due to drug marketing undermine patient safety and public health 2Health News:Inverse benefits due to drug marketing undermine patient safety and public health 3Health News:Rep. Giffords Continues to Recover From Gunshot Wound 2Health News:Rep. Giffords Continues to Recover From Gunshot Wound 3Health News:Health Disparities Persist in U.S., Report Shows 2Health News:Driving simulators help older adults improve their road skills 2Health News:New tool for cell research may help unravel secrets of disease 2Health News:US Department of Defense supports study of brain, eye injuries in military personnel 2
... Anchor is available in 3.5 mm, 5 mm ... minor diameter and a cancellous screw thread design ... laser mark on the distal part of the ... eyelets. When the anchor is inserted, the vertical ...
... - As easy to use as its ... demanding medical justification of therapeutic procedures. For ... tract symptoms (LUTS), that requires urodynamics. ... becoming routine in the office environment, with ...
... The FASTak II Suture Anchor is a ... that is inserted directly into bone without predrilling ... the Tear Drop Handle, Keyless Chuck or the ... and SLAP repairs as well as other small ...
... offer the best bioabsorbable solution for soft ... thread design and small core diameter provide ... braided suture loop is molded into the ... eyelet that virtually eliminates abrasion to attached ...
Medicine Products: